Skip to product information
1 of 1

$182

$182

Infectious disease biotech Bluejay raises $182M for hepatitis trials $182 A shift of NZ Defence Force's IT to the cloud and improved connectivity between Defence headquarters and bases were meant to be $182 Sionna raises another $182M to challenge Vertex in cystic fibrosis The Boston startup has amassed a pipeline of drugs it believes can fully

convert $182 $182 Top Quintile $1,420 80–90th Percent $505 90–95th Percent $907 95–99th Percent $1,828 Top 1 Percent $11,474 Source: Tax Policy Center, T11–0253, Tax

Regular price 121.00 ₹ INR
Regular price Sale price 121.00 ₹ INR
Sale Sold out
View full details